Clinical Trials Logo

Acrophobia clinical trials

View clinical trials related to Acrophobia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05841329 Completed - Clinical trials for Transcranial Direct Current Stimulation

Efficacy of tDCS to Enhance Virtual Reality Exposure Therapy Response in Acrophobia

Start date: August 6, 2020
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to examine whether transcranial direct current stimulation(tDCS) can enhance the effect of virtual reality exposure therapy(VRET) in acrophobia in college students with significant fear of heights. The main question it aims to answer are: • the enhancement of tDCS on the effect of VRET Participants will randomly allocated to tDCS active stimulated group and sham stimulated group and receive VRET.

NCT ID: NCT05780203 Completed - Acrophobia Clinical Trials

CBM in the Context of Exposure for Acrophobia

Start date: April 11, 2023
Phase: N/A
Study type: Interventional

The proposed study will apply a one-session exposure treatment combined with CBM training modifying interpretational processing biases versus a sham training in acrophobic individuals. The main aim is to advance our understanding of the mechanisms underlying exposure treatment.

NCT ID: NCT04975854 Completed - Anxiety Disorders Clinical Trials

Virtual Reality Exposure Therapy for Acrophobia

Start date: July 13, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to examine the efficacy of virtual reality exposure therapy (VRET) as a treatment for specific phobia (acrophobia). The study will randomly assign 42 participants with acrophobia to one of two conditions: a) the experimental condition (consisting of 3 sessions of virtual reality exposure) or b) a control condition. Both groups will receive short information session about general principles of exposure therapy before the start of the study. After the end of the study, the waitlist group will be invited to attend the short version (one or two-sessions) of the VRET. Both groups will receive a final follow-up questionnaires 2 months after the last session.

NCT ID: NCT04737915 Completed - Anxiety Disorder Clinical Trials

Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights

Start date: June 11, 2018
Phase: N/A
Study type: Interventional

This study randomly assigned 114 participants with significant fear of heights to one of three conditions: a) a single session of virtual reality exposure; b) a single session of in vivo exposure; or c) a control condition. The aim of this study was to compare the efficacy of virtual reality exposure to the efficacy of in vivo exposure or no exposure for participants with significant fear of heights.

NCT ID: NCT04620447 Completed - Anxiety Clinical Trials

Intelligent Virtual Reality Therapy System and Testing Its Clinical Efficacy

IVRTS
Start date: February 5, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Objective: To take the existing VR technology to the next level, the investigators developed a novel Intelligent Virtual Reality Therapy System (IVRTS). The objective of this project had three aspects: Namely, development of the novel IVRTS technology involving the development of a hardware device, development of Artificially Intelligent Psychotherapeutic software-interface and testing it's clinical efficacy. Methods: It used a two-phased methodology; Development of the novel technology and testing its Clinical Efficacy. After development of Novel IVRTS. A 7-week intervention was designed for each subject. The sample of 500 patients, meeting the criteria of Acrophobia and Anxiety, underwent the interventions at The GTB hospital (The University of Delhi), for a total 3500 sessions, ranging 5250 hours for over 2 years. The subjects were randomly divided into 4 groups: IVRTS Group, Mindfulness group, CBT group and Control Group. The ethics committee and clinical trial registration number is 33011. Development of this technology would be a land-mark innovation.

NCT ID: NCT03387254 Completed - Acrophobia Clinical Trials

Virtual Reality and Brain Stimulation, an Experiential Approach

REVISTIM-X
Start date: June 4, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to assess feasibility, acceptability and efficacy of two VRET (Virtual Reality Exposition Therapy)session associated with either active anodal tDCS or sham tDCS on the ventromedial prefrontal cortex to decrease anxiety related to visual height intolerance